Joel Greenblatt’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,710
Closed -$539K 1799
2026
Q1
$539K Sell
14,710
-4,540
-24% -$179K ﹤0.01% 1474
2025
Q4
$878K Buy
19,250
+4,528
+31% +$202K ﹤0.01% 1297
2025
Q3
$623K Buy
14,722
+2
+0% +$75 ﹤0.01% 1337
2025
Q2
$458K Buy
14,720
+2,682
+22% +$72.6K ﹤0.01% 1349
2025
Q1
$296K Buy
+12,038
New +$334K ﹤0.01% 1369
2019
Q2
Sell
-7,774
Closed -$227K 1128
2019
Q1
$227K Sell
7,774
-6,121
-44% -$175K ﹤0.01% 1076
2018
Q4
$394K Buy
+13,895
New +$418K 0.01% 809

Other funds holding AORT

Joel Greenblatt's AORT Position: Q2 2026 in Review

Joel Greenblatt sold out of Artivion (AORT) in Q2 2026, closing a stake of 14,710 shares — an estimated $539K sold.

Joel Greenblatt first reported a position in AORT in Q4 2018 and held it in 7 quarters. The position peaked at $878K in Q4 2025. 205 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Joel Greenblatt reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Joel Greenblatt sold 14,710 Artivion shares in Q2 2026, an estimated $539K.
  • Joel Greenblatt first reported a position in Artivion in Q4 2018 and held it in 7 quarters.
  • Joel Greenblatt's Artivion position peaked at $878K in Q4 2025.
  • 205 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.